2-16-11 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com

Caroline Valetkevitch, Reuters

Wall Street rises on M&A, Dell earns

NEW YORK (Reuters) – U.S. stocks advanced on Wednesday after stronger-than-expected Dell earnings and a flurry of deal news.

The benchmark S&P 500 rose above 1,333.58, double the intraday low hit in early March 2009.

Dell Inc DELL, the world's No. 2 personal computer maker, flew past profit and margins estimates in the latest show of strength from corporate America that has helped lift stocks. Dell jumped 9.9 percent to $15.28.

French drugmaker Sanofi-Aventis SA SASY agreed to buy Genzyme Corp GENZ for $20.1 billion in cash, pushing up Genzyme shares 1.6 percent to $75.48.

In another proposed deal, activist investor Nelson Peltz's Trian Group offered to acquire Family Dollar Stores Inc FDO for $55 to $60 per share in cash, giving the company an implied value of $7.6 billion. Family Dollar soared 23.7 percent to $54.40.

Yesterday's Top Performing Small Cap Stock:

Total Nutraceutical Solutions, Inc. TNUS

Total Nutraceutical Solutions, Inc. was a SmallCapVoice.com top performer closing up over 6% on trading volume of 59,500 shares.

Total Nutraceutical Solutions, Inc., (TNS) a global biotechnology leader in whole food mushroom research and development, focuses on discovering, formulating and marketing products composed primarily of organic natural whole mushroom foods, containing bioactive nutrients, such as L-Ergothioneine and Vitamin D, with potential health benefits. The Company's scientific strategy is to specialize in the development of production and analytic technologies for food and nutritional supplements mainly composed of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to their novel preventative health care formulations and nutritional approaches for a wide variety of human conditions and illnesses, Total Nutraceutical Solutions is also involved in the development, acquisition and ownership of breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.

Today's SmallCapVoice.com Hot Stock to Watch:

Tootie Pie Company TOOT

Tootie Pie Company Reports Record Revenues

Adds Three New Tootie Pie Gourmet Cafés

Feb. 15, 2011 (Business Wire) — Tootie Pie Company, Inc. TOOT reported record revenues of $1,061,215 for the period ending December 31, 2010, versus revenues of $910,837 for the same period in 2009, a 17% improvement.

“We will continue to invest in our accelerated growth model, as represented by our Gourmet Cafés,” said Don Merrill, Tootie Pie Company's President & CEO. “The Cafés represent significant revenue growth, but they also enable us to sell more pie at higher margins. We believe they are the next logical extension of our brand.”

SmallCapVoice Clients' News

Forex International Trading Corp. FXIT

Forex International Trading Corp. Retains Consultants Shareholder Intelligence Services

Feb. 16, 2011 (Business Wire) — Forex International Trading Corp. (the “Company”) FXIT, a company, through its affiliates, is principally engaged in offering a web-based foreign currency trading platform to non-US residents, professionals and retail clients, today announced that it has retained Shareholder Intelligence Services, LLC (“ShareIntel”), an application service provider to obtain, aggregate, track and analyze shareholder trading information on the Company.

Other Small Cap News

Cyanotech Corporation CYAN

UC Davis Research Study Indicates that Cyanotech's Spirulina Pacifica® May Counter Anemia and Declining Immune Function in Persons Over Age 50

UC Davis Study Leaders Urge Large-Scale Random Clinical Trials Be Undertaken to Confirm Benefits of Hawaiian Spirulina Supplements for Senior Citizens

KAILUA KONA, Hawaii–(BUSINESS WIRE)– Cyanotech Corporation (Nasdaq Capital Market: CYAN), world leader in microalgae-based health and nutrition supplements, announced today that researchers at the University of California at Davis have determined that microalgae-based Hawaiian Spirulina Pacifica® may improve immune function and ameliorate anemia in persons over 50. Results of the UC Davis study will be published in the March edition of the journal Cellular & Molecular Immunology, in a paper entitled, ”The effects of Spirulina on anemia and immune function in senior citizens.”

SkyPeople Fruit Juice, Inc. SPU

SkyPeople Launches ‘Qian Mei Duo(TM)' High-Fiber Fruit Juice Beverages

New product line forecasted to contribute $9.0 million in revenues for 2011

XI'AN, China, Feb. 16, 2011 /PRNewswire-Asia-FirstCall/ — SkyPeople Fruit Juice, Inc. SPU (“SkyPeople” or “the Company”) a processor and manufacturer of kiwifruit, apple, pear and other concentrated specialty fruit juices and manufacturer of Hedetang-branded fruit beverages, today announced a new fruit beverages brand, Qian Mei Duo ™ (“Good for You”), targeted to one of China's strongest consumer demographics, 18 to 29 year old Chinese women.

Cerus Corporation CERS

Cerus' INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

CONCORD, Calif.–(BUSINESS WIRE)– Cerus Corporation CERS announced today that it has been granted orphan drug status for plasma prepared with the INTERCEPT Blood System for treatment of thrombotic thrombocytopenic purpura (TTP). TTP is a rare, life-threatening blood disorder that typically requires transfusion with large volumes of plasma. Orphan drugs are required to establish safety and efficacy prior to approval by the United States Food and Drug Administration (FDA). The designation facilitates the application process in order to encourage development of new therapies to treat rare conditions and diseases.

Threshold Pharmaceuticals, Inc. THLD

Threshold Pharmaceuticals Announces Agreement With the FDA on a Special Protocol Assessment for Planned Phase 3 TH-302 Combination Trial in Advanced Soft Tissue Sarcoma

REDWOOD CITY, Calif., Feb. 16, 2011 (GLOBE NEWSWIRE) — Threshold Pharmaceuticals, Inc. THLD today announced that the Company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 randomized trial of TH-302 in patients with soft tissue sarcoma. This pivotal trial is expected to begin in the middle of 2011, and will enroll patients with metastatic or locally advanced unresectable soft tissue sarcoma who have not previously received chemotherapy outside the adjuvant or neoadjuvant setting. The trial is designed to evaluate the efficacy and safety of TH-302 in combination with doxorubicin, compared to doxorubicin alone.

Dynatronics Corporation DYNT

Dynatronics Announces $1 Million Stock Buyback Program

Dynatronics to Repurchase Up to $1 Million of the Company's Common Stock

“This decision reflects the confidence of management and our board of directors in the future of the company and our commitment to increasing shareholder value,” said Kelvyn H. Cullimore, president of Dynatronics. “Based on recent announcements of contract awards with large group purchasing organizations and other anticipated opportunities, we expect to see revenues continue to grow over the next two years. Based on this outlook and other factors, this newly authorized $1 million share repurchase plan provides us with the flexibility, when market conditions warrant, to reduce our outstanding shares and offset potential future dilution from awards under our equity-based compensation plans.” Since January 3, 2011, the Company repurchased approximately 72,000 shares under a prior formal plan of repurchase.

Ballard Power Systems BLDP

Ballard Fuel Cell Modules To Power Fleet of Clean Energy Transit Buses in Norway

VANCOUVER, Feb. 15 /PRNewswire/ – Ballard Power Systems BLD BLDP announced that it has entered into a contract for the supply of fuel cell power modules to power five zero-emission hydrogen fuel cell buses operated by the HyNor Oslo Buss group, to service the greater Oslo area.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

The SmallCapVoice.com, Inc. Daily Highlights is an electronic publication, and is for informational purposes only. The Small Cap Voice Daily Highlights covers both client and non client issuers. Non client issuer's news is listed under other small cap news. SmallCapVoice is an electronic publication providing information on selected public companies. All companies profiled on this website pay cash or restricted stock to SmallCapVoice as consideration for the electronic dissemination of the company's information and our comments about the company. Section 17(b) of the Securities Act of 1933 requires that SmallCapVoice fully disclose the type consideration (i.e. cash, restricted stock, and restricted stock with registration rights, stock options, stock warrants, or other type consideration) and the specific amount of the consideration our company receives or will receive, directly or indirectly, from an issuer, underwriter, or dealer. No information contained in our website, e-mail communications or our publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. SmallCapVoice is not a registered investment advisor or a registered securities broker dealer. We do not undertake or represent to make investment recommendations or to give advice pertaining to the purchase or sale of the securities mentioned in our web site, e-mail communications or publications. The information contained in our website, e-mail communications and publications are carefully compiled by SmallCapVoice from public sources that we believe to be reliable. SmallCapVoice, however, does not guarantee the accuracy of any information contained in our website, e-mail communications or publications. This material is not a substitute for either one's own thorough investigation of an investment opportunity or the exercise of good business judgment. SmallCapVoice does not endorse, independently verify, or assert the truthfulness or reliability of any statements or data obtained from third party sources that are published by us about the profiled companies in our website articles, e-mail communications or publications, but we do not publish information that we know is incorrect. Investors should not rely solely on the information contained in our website, e-mail communications or publications when making investment decisions. Instead, investors should use the information provided on the profiled companies as a starting point for conducting additional research that will permit them to form their own opinions regarding the appropriateness of an investment in the profiled company's securities. SmallCapVoice does not warrant, represent or guaranty that there has been no change in the affairs of the profiled company since the date that information was published on this website, in e-mail communications or in our publications regarding a profiled company or after the date of the profiled company's press releases or other information disseminated via our website or publications. If you become aware of any change of circumstances related to any website article, e-mail communication or publication, please notify us immediately. See the Contact Us page for the appropriate e-mail address. The information contained in our website, e-mail communications and publications pertains to microcap, small cap and/or other thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these type of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities. SmallCapVoice may liquidate the stock consideration it receives at any time it deems it appropriate to do so after the required six-month holding period has run after the completion of the services for which SmallCapVoice was paid in stock. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company's securities. The following companies have paid, and/or have agreed to pay SmallCapVoice to: distribute the company's information and reports on this website, to send e-mail communications; to send publications by mail, to post company Internet links on our website, and to compile and/or to distribute reports in an e-mail newsletter.

We encourage our readers to use caution when investing and educate themselves at the web sites of the Securities and Exchange Commission (“SEC”) at www.sec.gov and/or the National Association of Securities Dealers (“NASD”) at www.nasd.com. We encourage you to study the SEC's policies regarding online newsletters at http://www.sec.gov/answers/newsltr.htm. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our site.

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com